| Position: Home>News> |
| Position: Home>News> |
More than 500 cases of mostly minor side effects have been reported in girls and women who got the new cervical cancer vaccine, but government health officials say no additional warning labels are needed. Many of the reports involved fainting, but teens tend to faint from vaccinations anyway, health experts said, and the number of cases doesn't exceed what was expected. "There is absolutely no reason to think that there is anything in this vaccine, as opposed to another vaccine, that's going to make people more likely to faint," said Dr. John Iskander, of the immunization safety office with the U.S. Centers for Disease Control and Prevention. At issue is Gardasil, a three-dose vaccine by Merck & Co. approved by the government last June for females ages 9 to 26. The vaccine protects against strains of the human papillomavirus, or HPV, which causes cervical, vulvar and vaginal cancers and genital warts. Data about side effects will be presented According to an advance report shared with The Associated Press, there have been 542 adverse health complaints. Injection site soreness was reported by nearly 20 percent, fainting or dizziness was reported by 11 percent, and fever or nausea was reported in 9 percent. None of the girls or women who fainted had a serious injury from falling unconscious, and there were no deaths. However, health officials recommend a 15-minute waiting period after the shot before leaving the doctor's office, in case of fainting or other problems. Health officials have been cautiously watching for reports of Guillain-Barre syndrome, a paralyzing side effect that has been associated with a few other vaccines. In the reporting period, there were three such cases. "Based on these numbers, it's not worrisome to us that there's any sort of association between the vaccine" and Guillain-Barre, Iskander said. Advocacy group released Gardasil warning But Iskander said there's no evidence Gardasil is harmful in combination with other vaccines.
The advocacy group also questioned a movement by some state legislatures to order the vaccine be given to all girls. "We just don't know enough to be mandating Gardasil for anyone, much less vulnerable 11- to 12-year-old girls entering puberty," said Barbara Loe Fisher, the organization's president, in a prepared statement. On Tuesday, Merck announced it was dropping its lobbying campaign to persuade states to make the cancer vaccine required for adolescent girls attending public school. ?2007 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. |
|
Top Stories
Prostate cancer treatment might shorten penisHormone therapy plus radiation reduced aver
THURSDAY, July 6 (HealthDay News) -- Only 38 percent of teen and young adult sexual as
Food pyramid to be erected in stores at lastRevised nutrition triangle promoting better
MONDAY, June 26 (HealthDay News) -- Scientists believe they\'ve found a way to spot au
Activists raise outcry over stunting disabled girlThey've filed complaints, want AMA to
Ward off cancer with bad breathPowerful antioxidants in onions and garlic may offer prot
|
|
Related
Teeniest preemie finally heads homeBaby is healthy, but will still need supplemental oxy Britain to use donor eggs for stem cell researchWomen will be compensated up to $500 for Group sues feds over medical marijuana claimGovernment accused of denying 'sick and dyin As pets live longer, doggie dementia on the riseSenility trend in people also occurring
Drugmakers to add warnings to ADHD pillsFDA wants new guides to alert patients to heart
3 given organs from HIV-positive donorKidney, liver transplants due to 'tragic human err
Herpes drug found to slow HIV advanceWomen who took Valtrex for three months had lower l
Prepackaged mushrooms recalled for E. coliTests show possible contamination in BJ's Whol
|

